Skip to main content
. 2017 Mar 16;7:44782. doi: 10.1038/srep44782

Table 1. Effects of chitosan oligosaccharide supplementation on the amniotic fluid antioxidant status of sowsa.

Items Treatmentsb
P-value
CON COS
SODc (U/mL) 60.26 ± 4.80 69.07 ± 6.46* 0.023
CATd (U/mL) 3.61 ± 0.60 5.22 ± 0.53** <0.001
ASAe (U/L) 89.29 ± 1.86 104.68 ± 6.44** 0.005
AHRf (U/mL) 398.23 ± 12.72 426.41 ± 14.15* 0.011
T-AOCg (U/mL) 2.64 ± 0.16 3.26 ± 0.59* 0.048
GSHh (mg/mL) 0.29 ± 0.06 0.31 ± 0.06 0.598
MDAi (nm/mL) 4.90 ± 0.71 4.56 ± 0.56 0.386

*P < 0.05 versus the CON group. **P < 0.01 versus the CON group.

aValues are means of six replications per treatment.

bCON: A corn–soybean basal diet; COS: Chitosan oligosaccharide (the basal diet supplemented with 100 mg/kg chitosan oligosaccharide).

cSOD: Superoxyde dismutase.

dCAT: Catalase.

eASA: Anti-superoxide anion.

fAHR: Anti-hydroxyl radical.

gT-AOC: Total antioxidant capacity.

hGSH: Glutathione.

iMDA: Malondialdehyde.